News archive
296 results
-
A report on the sales channel of over-the-counter drugs emphasises safe and appropriate pharmaceutical sales
-
Fimea has defined further measures for non-transferred clinical trials
-
Prices of clinical trials to be lowered in special cases
-
Open data addresses to change at the end of September
-
Applying for a special permit electronically is possible soon
-
Fimea has classified BioNix, containing benzyl benzoate, as a veterinary medicinal product in Finland
-
Swedish video on the safe use of medicines published
-
Annual report 2023 on the supervision of the quality and safety of transplants of human origin has been published
-
Anaphylactic reactions in cattle increased in Europe
-
Safety limits for medicinal products containing estragole have been revised: actions required from marketing authorisation and registration holders
-
Instructions for marketing authorisation holders: Patient and reporter information to be submitted to EudraVigilance (EVPM)
-
Fimea published its sustainability report for 2023, aims for a sustainable future
-
New Decree on fees chargeable for clinical trials under the EU Clinical Trials Regulation to enter into force on 1 May 2024
-
A pilot project between Fimea, university hospitals and Sitra is emerging as a model for providing additional evidence on new pharmacotherapies
-
FINOSE now includes all Nordic countries
-
Fimea and Tukes warn against the Lemon Bottle product intended for dissolving fat
-
Adopt use of Fimea's information products that support medication safety Meds75+ and the updated National High-risk Medicines Classification
-
Starting from 1 April 2024, enoxaparin products can be substituted at a pharmacy with a more affordable alternative
-
New price list for commercially priced services to be introduced from 1 April 2024
-
Patient pharmacotherapy checklist supports medication counselling at different stages of treatment
Showing 1 - 20 / 296
